CIK 0001020214 · Accelerated filer
CERUS CORP
Sign in to watch- Ticker
- CERS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 680262011
- Phone
- 9252886000
- Business address
- 1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale Chief Legal Officer sold 30,000 shares at $2.98 ($89,529)
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale Chief Executive Officer sold 16,666 shares at $3.16 ($52,665)
- 144 Insider Sale of Securities
- 8-K Event Executive or director change
- 4 Planned sale Chief Financial Officer sold 33,676 shares at $2.94 ($99,105)
- 4 Planned sale Chief Operating Officer sold 42,359 shares at $2.94 ($124,658)
- 4 Planned sale Chief Legal Officer sold 24,329 shares at $2.94 ($71,598)
- 4 Planned sale President and CEO sold 101,919 shares at $2.94 ($299,937)
- 4 Open-market sale Director sold 20,454 shares at $2.60 ($53,180)
- 144 Insider Sale of Securities
Page 1 of 76 · 1,513 filings